Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$259.0 - $414.71 $1.62 Million - $2.59 Million
-6,250 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$242.95 - $284.63 $1.52 Million - $1.78 Million
6,250 New
6,250 $1.75 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.5B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Berry Street Capital Management LLP Portfolio

Follow Berry Street Capital Management LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Berry Street Capital Management LLP, based on Form 13F filings with the SEC.

News

Stay updated on Berry Street Capital Management LLP with notifications on news.